Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...

The compiler infers, but does not take instructions. There is no syntax for explicit type declarations yet, and the new type ...

Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

Recursion Pharmaceuticals is trying to prove that AI’s next big winner can also come from biotech, and not just from the tech ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Google DeepMind's new report maps four pathways from AGI to artificial superintelligence. Here's how scaling, paradigm shifts ...

Anthropic recursive self improvement, Brian Patrick Green tech ethics, AI regulation slowdown, Pope Leo XIV AI encyclical, ...

A Catholic expert on artificial intelligence is commending recent calls by AI research firm Anthropic to rein in the technology amid a significant acceleration in its growth.

Spread the love“`html The landscape of artificial intelligence is constantly evolving, and the idea of Recursive Self-Improvement (RSI) is gaining traction as a potential game-changer. With ...

AbCellera has an AI-driven antibody discovery platform, $650M liquidity, and an upcoming Phase 2 catalyst. Click here to read ...

As AI moves from experimentation to business-critical operations, leadership teams will need to look beyond pilot outcomes ...

Recursion Pharmaceuticals (NasdaqGS:RXRX) reported positive early clinical data from its AI driven drug discovery programs. The company highlighted progress in oncology and rare disease candidates in ...